• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza virus infection causes global RNAPII termination defects

tetano

Editor, Senior Moderator
Nat Struct Mol Biol. 2018 Sep 3. doi: 10.1038/s41594-018-0124-7. [Epub ahead of print]
[h=1]Influenza virus infection causes global RNAPII termination defects.[/h] Zhao N[SUP]1,[/SUP][SUP]2[/SUP], Sebastiano V[SUP]3,[/SUP][SUP]4[/SUP], Moshkina N[SUP]1,[/SUP][SUP]2[/SUP], Mena N[SUP]1,[/SUP][SUP]2[/SUP], Hultquist J[SUP]5[/SUP], Jimenez-Morales D[SUP]6[/SUP], Ma Y[SUP]1,[/SUP][SUP]2[/SUP], Rialdi A[SUP]1,[/SUP][SUP]2[/SUP], Albrecht R[SUP]1,[/SUP][SUP]2[/SUP], Fenouil R[SUP]7[/SUP], S?nchez-Aparicio MT[SUP]1,[/SUP][SUP]2[/SUP], Ayllon J[SUP]1,[/SUP][SUP]2[/SUP], Ravisankar S[SUP]3,[/SUP][SUP]4[/SUP], Haddad B[SUP]3,[/SUP][SUP]4[/SUP], Ho JSY[SUP]8[/SUP], Low D[SUP]8[/SUP], Jin J[SUP]9[/SUP], Yurchenko V[SUP]10[/SUP], Prinjha RK[SUP]11[/SUP], Tarakhovsky A[SUP]12[/SUP], Squatrito M[SUP]13[/SUP], Pinto D[SUP]14[/SUP], Allette K[SUP]15[/SUP], Byun M[SUP]16[/SUP], Smith ML[SUP]15[/SUP], Sebra R[SUP]15[/SUP], Guccione E[SUP]8[/SUP], Tumpey T[SUP]17[/SUP], Krogan N[SUP]6[/SUP], Greenbaum B[SUP]18,[/SUP][SUP]19,[/SUP][SUP]20[/SUP], van Bakel H[SUP]7[/SUP], Garc?a-Sastre A[SUP]1,[/SUP][SUP]2,[/SUP][SUP]21[/SUP], Marazzi I[SUP]22,[/SUP][SUP]23[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Viral infection perturbs host cells and can be used to uncover regulatory mechanisms controlling cellular responses and susceptibility to infections. Using cell biological, biochemical, and genetic tools, we reveal that influenza A virus (IAV) infection induces global transcriptional defects at the 3' ends of active host genes and RNA polymerase II (RNAPII) run-through into extragenic regions. Deregulated RNAPII leads to expression of aberrant RNAs (3' extensions and host-gene fusions) that ultimately cause global transcriptional downregulation of physiological transcripts, an effect influencing antiviral response and virulence. This phenomenon occurs with multiple strains of IAV, is dependent on influenza NS1 protein, and can be modulated by SUMOylation of an intrinsically disordered region (IDR) of NS1 expressed by the 1918 pandemic IAV strain. Our data identify a strategy used by IAV to suppress host gene expression and indicate that polymorphisms in IDRs of viral proteins can affect the outcome of an infection.


PMID: 30177761 DOI: 10.1038/s41594-018-0124-7
 
Back
Top Bottom